Name (Synonyms) | Correlation | |
---|---|---|
drug711 | Daily Monitoring Wiki | 1.00 |
drug558 | Chinese medicine treatment Wiki | 1.00 |
drug2708 | YinHu QingWen Decoction(low dose) Wiki | 1.00 |
drug2707 | YinHu QingWen Decoction Wiki | 1.00 |
drug843 | Emotional Support Plan Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D002659 | Child Development Disorders, Pervasive NIH | 0.58 |
D001321 | Autistic Disorder NIH | 0.50 |
D000067877 | Autism Spectrum Disorder NIH | 0.41 |
D013315 | Stress, Psychological NIH | 0.21 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0000717 | Autism HPO | 0.50 |
HP:0000729 | Autistic behavior HPO | 0.41 |
There is one clinical trial.
In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia caused by CoVID-19, and the number of cases of infection with CoVID-19 identified in Wuhan increased markedly over the later part of January 2020, with cases identified in multiple other Provinces of China and internationally. Given no specific antiviral therapy for CoVID-19 infection and the availability of Yinhu Qingwen Decoction as a potential antiviral Chinese medicine based on vivo antiviral studies in CoVID-19, this randomized,three-arm controlled, single-blind trial will evaluate the efficacy and safety of Yinhu Qingwen Decoction (Granula) in patients hospitalized with mild or common CoVID-19 respiratory disease.
Description: The clinical recovery time is defined as the time from initiation of study treatment (active or placebo) until normalisation of fever, respiratory rate, and oxygen saturation, and alleviation of cough, sustained for at least 72 hours. Normalisation and alleviation criteria: (1) Fever: ≤36.6°C or -axilla, ≤37.2 °C oral or ≤37.8°C rectal or tympanic;(2)Respiratory rate - ≤24/minute on room air; 3) Oxygen saturation - >94% on room air; (4) Cough - mild or absent on a patient reported scale (cough symptoms score ≤ 2 points).
Measure: Mean clinical recovery time (hours) Time: up to 28 daysDescription: Defined as: SPO2≤ 93% on room air or PaO2/FiO2≤ 300mmHg and requirement for supplemental oxygen or more advanced ventilator support.
Measure: Frequency of respiratory progression Time: up to 28 daysDescription: Severe case is defined as respiratory rate ≥30/minute on room air;or Oxygen saturation - ≤94% on room air;or PaO2/FiO2≤300mmHg.
Measure: Severe case incidence Time: up to 28 days